Users Online: 179
Home
About us
Editorial board
Ahead of print
Browse Articles
Search
Archives
Submit article
Instructions
Subscribe
Contacts
Login
» Articles published recently
To view other articles click corresponding year from the navigation links on the left side.
All
|
Brief Communication
|
Brief Communications
|
Case Report
|
Case Reports
|
Commentary
|
Corrected and Republished
|
Editorial
|
Editorials
|
Erratum
|
Letter to Editor
|
Letter to Editors
|
Letters to Editor
|
Mini-Review Article
|
Opinion
|
Original Article
|
Original Articles
|
Original Research
|
Retraction Notice
|
Review Article
|
Review Articles
|
Review Protocol
|
Review Study
|
Short Communications
|
Systematic Review and Meta.Analysis
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Show all abstracts
Show selected abstracts
Export selected to
Add to my list
Original Article:
Effects of omega-3 supplement in the treatment of patients with bipolar I disorder
Jalal Shakeri, Maryam Khanegi, Sanobar Golshani, Vahid Farnia, Faeze Tatari, Mostafa Alikhani, Roghih Nooripour, Mohammad Saeed Ghezelbash
Int J Prev Med
2016, 7:77 (19 May 2016)
DOI
:10.4103/2008-7802.182734
PMID
:27280013
Background:
Fatty acids play various physiological roles in the organism; they are crucial for the structure of cell membranes, metabolic processes, transmission of nerve impulses and brain functions. In recent years, particular attention has been paid to the rich sources of omega-3 for the treatment of many diseases, especially mental illnesses. The present study aimed to investigate the effects of omega-3 supplement in the treatment of patients with bipolar I disorder (BID).
Methods:
In this double-blind clinical trial, 100 patients suffering from BIDs were randomly divided into two, i.e. control (
n
= 50) and experimental (
n
= 50) groups. In addition to the other standard treatments, 1000 mg of omega-3 supplement was given to the experimental group on daily basis for 3 months and placebo was given to the control group. The Young Mania Rating Scale was completed for both groups before and after the intervention. Afterward, data were analyzed using paired
t
-test, independent
t
-test, and Chi-square test.
Results:
Before intervention, mean severity of mania in the experimental group (23.50 ± 7.02) and control group (23.70 ± 8.09) was not significant (
P
≤ 0.89). The difference after the intervention in the experimental group (10.64 ± 3.3) and control group (20.12 ± 6.78) was significant (
P
< 0.01). The mean intensity of mania before (23.50 ± 7.02) and after (10.64 ± 3.3) intervention reported to be significant at
P
< 0.05.
Conclusions:
Since omega-3 supplement was effective for the treatment of BID, it is suggested to use omega-3 supplements as an adjuvant therapy along with the other pharmacotherapies.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (5) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Original Article:
High fasting plasma glucose mortality effect: A comparative risk assessment in 25-64 years old Iranian population
Niloofar Peykari, Moghaddam Sahar Saeedi, Shirin Djalalinia, Amir Kasaeian, Ali Sheidaei, Anita Mansouri, Younes Mohammadi, Mahboubeh Parsaeian, Parinaz Mehdipour, Bagher Larijani, Farshad Farzadfar
Int J Prev Med
2016, 7:75 (19 May 2016)
DOI
:10.4103/2008-7802.182732
PMID
:27280011
Background:
High fasting plasma glucose (FPG) is one of the main leading risk factors of ischemic heart disease (IHD), stroke, and chronic kidney diseases (CKDs). We estimated population attributable fraction (PAF) and attributed death of these fatal outcomes of high FPG at national and subnational levels in 25-64 years old Iranian adult.
Methods:
We used national and subnational data of the Non-Communicable Disease Surveillance Survey for exposure to risk factors in 2005 and 2011 among Iranian adults of 25-64 years old. For estimating the attributed death, using the death registration system data of Iran, we multiply the cause-specific PAFs by the number of outcome-specific deaths.
Results:
In Iran, high FPG was responsible for about 31% of attributed total deaths of IHD, stroke, and CKD in 2011. The related attributed deaths had increased from 2005 to 2011. In females, the PAFs for the effect of high FPG on IHD, stroke, and CKD were higher in 2011 than 2005 in all age groups. In males, this increase has occurred in over 45 years old. The highest PAFs of high FPG outcomes mostly related to central provinces of Iran. The central region of Iran had the highest and the southeast of the country had the lowest levels of attributed deaths.
Conclusions:
Considering the global 25 × 25 targets for noncommunicable disease mortality reduction, high FPG as a leading risk factor of fatal outcomes should be more targeted through the dietary, behavioral, and pharmacological interventions in Iran.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (1) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Original Article:
Validity and reliability of health promoting lifestyle profile II in the Iranian elderly
Parisa Taheri Tanjani, Mojtaba Azadbakht, Gholamreza Garmaroudi, Robab Sahaf, Zohreh Fekrizadeh
Int J Prev Med
2016, 7:74 (19 May 2016)
DOI
:10.4103/2008-7802.182731
PMID
:27280010
Background:
With increasing age, the prevalence of chronic diseases increases. Since health-promoting behaviors (HPB) are considered a basic way of preventing diseases, especially chronic diseases, it is important to assess HPB. This study examines the validity and reliability of the Health Promoting Lifestyle Profile II (HPLP-II).
Methods:
This is a cross-sectional study which is conducted on 502 elderly individuals aged 60 and over in Tehran, Iran. In order to determine the validity, content and construct validity were used. The content validity index (CVI) was used to assess the content validity and to assess construct validity, confirmatory factor analysis (CFA), and item-total correlations were employed. For reliability, test-retest analysis was used, and the internal consistency of the HPLP-II was confirmed by Cronbach's alpha. For data analysis, SPSS-18 and Amos-7 software was used.
Results:
The mean age of the subjects was 66.3 ± 5.3 years. The CVI for the revised HPLP-II and all its subscales was higher than 0.82. The CFA confirmed a six-factor model aligned with the original HPLP-II. Pearson correlation coefficients between the revised HPLP-II and their items were in range of 0.27-0.65. Cronbach's alpha of the revised HPLP-II was obtained as 0.78 and for their subscales were in the range of 0.67-0.84. Intraclass correlation coefficient was obtained 0.79 (95% confidence interval: 0.59-0.86,
P
< 0.001).
Conclusions:
The Iranian HPLP-II scale is an appropriate tool for assessing HPBs of the Iranian elderly.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (15) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Original Article:
The direct medical costs of outpatient cares of Type 2 diabetes in Iran: A retrospective study
Majid Davari, Zahra Boroumand, Masoud Amini, Abolfazl Aslani, Mohsen Hosseini
Int J Prev Med
2016, 7:72 (4 May 2016)
DOI
:10.4103/2008-7802.181758
PMID
:27217937
Background:
Diabetes mellitus is a chronic disease which many factors are involved and is developing considerably worldwide. Increasing aging population and obesity in the societies has improved the scale of the type 2 diabetes significantly. The aim of this study was to determine the direct medical costs of outpatient cares of diabetes in Iran.
Methods:
Active patients of Isfahan Endocrinology and Metabolism Research Center (IEMRC) by the end of March 2011 were employed for data extraction. Type 2 diabetics were classified into 4 groups based on their therapeutic regimens. Type and frequency of health care services were extracted from the patients' profiles manually. The incidence of major diabetes complications were also examined from the subjects' profiles. The numbers of services used by the patients in different treatment groups were multiplied by the desired medical tariffs to calculate the direct medical costs.
Results:
2898 number of cases was reviewed in this study; 63.8 % women and 36.2% men. 4.3% of the patients were placed group I; 50.1% in group II, and 34.6% and 11% in groups III and IV respectively. The age distribution of the patients varied widely from 30 to 90 years; 5.8% between 30 and 39 years, 62.3% between 40 and 59, and 31.9% at 60 and over. Nephropathy (72.4%), and neuropathy (39%) were the most frequent adverse effect between the type 2 diabetics in Isfahan. The group III with spending $192.3 in total was absorbed the highest amount of the resources between the patients' groups. The average direct medical cost of outpatient cares of diabetics per year was 155.8 US $.
Conclusions:
The direct medical cost of diabetes management is progressed sharply in past years in Iran. Pharmaceutical expenditures was the main cost component of outpatient cares for diabetes. It is estimated that the Iranians directly spend approximately $4.05 milliard annually to manage 5.2 million diabetics in the country.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (6) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Original Article:
Tobacco use and its relationship with health complaints among employees of Kermanshah province, Iran
Nahid Khademi, Mehran Babanejad, Farid Najafi, Mohammad Reza Nikbakht, Behrooz Hamzeh, Nasrin Mohammadi
Int J Prev Med
2016, 7:71 (4 May 2016)
DOI
:10.4103/2008-7802.181757
PMID
:27226894
Background:
Identifying the pattern of tobacco use and its related factors in employees is crucial. This study aimed to investigate the pattern of tobacco use and its related factors in employees of Kermanshah Province, Iran.
Methods:
In 2012, 7129 employees were investigated in a cross-sectional study using the census method. Data on tobacco use and on several chronic diseases obtained using a standardized questionnaire on noncommunicable diseases risk factors of the World Health Organization through face-to-face interviews. Statistical analysis was performed based on the Chi-square test and multivariate logistic regression.
Results:
In general, the prevalence of tobacco use, smoking cigarettes, and smoking waterpipe was 9.9%, 8.9%, and 1.2% among the employees, respectively. Tobacco use was significantly higher in the age group over 40 (14.0%), in male gender (13.3%), in married individuals (10.8%) and in those with diploma and lower degree (16.4%), (
P
< 0.001). At the individual level, the odds ratio of tobacco use was 1.5 (95% confidence interval [CI]: 1.2-1.8) in hypertensive, 1.8 (95% CI: 1.2-2.6) in diabetic employees and 1.7 (95% CI: 1.3-2.3) in those with heart diseases, compared to healthy individuals. After adjusting for age, gender, marital status and educational level, there was not any significant relationship between tobacco use and health complaints and only the demographic variables remained significant.
Conclusions:
Preventive public health policies are mandatory especially in younger ages and male employees to promote their knowledge on disadvantages of tobacco use.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (1) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Advanced Search
Month wise articles
Figures next to the month indicate the number of articles in that month
2021
January
[
10
]
2020
December
[
11
]
November
[
7
]
October
[
11
]
September
[
17
]
August
[
15
]
July
[
9
]
June
[
6
]
May
[
4
]
April
[
3
]
March
[
4
]
February
[
14
]
January
[
9
]
2019
December
[
10
]
November
[
12
]
October
[
29
]
September
[
7
]
August
[
15
]
July
[
9
]
June
[
18
]
May
[
33
]
April
[
8
]
March
[
9
]
February
[
9
]
January
[
10
]
2018
December
[
8
]
November
[
7
]
October
[
9
]
August
[
6
]
July
[
7
]
June
[
7
]
May
[
7
]
April
[
5
]
March
[
6
]
February
[
15
]
January
[
2
]
2017
December
[
8
]
November
[
7
]
October
[
6
]
September
[
5
]
August
[
10
]
July
[
5
]
June
[
3
]
May
[
4
]
April
[
8
]
March
[
6
]
February
[
4
]
January
[
2
]
2016
December
[
4
]
November
[
2
]
October
[
6
]
September
[
11
]
August
[
5
]
July
[
7
]
June
[
7
]
May
[
5
]
April
[
7
]
March
[
12
]
February
[
9
]
January
[
9
]
2015
December
[
10
]
November
[
9
]
October
[
7
]
September
[
9
]
August
[
7
]
July
[
10
]
June
[
5
]
May
[
9
]
April
[
6
]
March
[
2
]
February
[
7
]
January
[
5
]
Sitemap
|
What's New
|
Feedback
|
Disclaimer
© International Journal of Preventive Medicine | Published by Wolters Kluwer -
Medknow
Online since 2
nd
January, 2015